News
Antibiotic from snake venom is now effective against skin disease
In the battle against increasing resistance towards antibiotics, a major breakthrough has been achieved with the development of antibiotics based on the venom from snakes, scorpions and other poisonous animals.
Dutch company Kiadis Pharma raises €28M to push cancer cell therapy to European market
The Dutch Kiadis Pharma has raised €27.6M in a private placement to fund the clinical development of immune cell therapies treating blood cancer.
Life Sciences & Health grant for gene therapy partnership between the Amsterdam Center for Neurogenomics & Cognitive Research and DegenRx
Center for Neurogenomics & Cognitive Research (CNCR) and DegenRx B.V. a biopharmaceutical company in the field of neurodegenerative diseases, announced today that they have been awarded a grant from the Top Sector Life Sciences & Health (Health~Holland) for their joint research program on antibody-based gene therapy for the treatment of Alzheimer’s disease (AD).
Dutch Cabinet establishes 25 missions for the future: 5 address Health & Care
On 26 April, the Dutch Cabinet decided in the Council of Ministers to implement the mission-driven innovation policy. In total, eight ministries, together with entrepreneurs and knowledge institutions from the nine different top sectors, have established 25 missions. These will strengthen the Dutch economy within four societal challenges: 1) Energy Transition & Sustainability, 2) Agriculture, Water & Food, 3) Health & Care and 4) Security & Key Enabling Technologies.
Three medical innovations nominated as finalists new National Icons
Tien innovatieve technologieën zijn genomineerd als finalisten voor de verkiezing van de nieuwe Nationale Iconen. Het gaat om Nederlandse oplossingen voor wereldwijde vraagstukken op het gebied van gezondheid, energie, digitalisering, circulaire materialen en mobiliteit. Het kabinet maakt in september bekend wie de uiteindelijke winnaars zijn.
Full house at strategic conference Health & Care
With the recent announcement of the mission-driven innovation policy, the Top Sector Life Sciences & Health (LSH) has been appointed to coordinate the realisation of the new Knowledge & Innovation Agenda (KIA) and Contract (KIC) 2020-2023 concerning the global challenges of Health & Care. The Top Sector therefore organised a strategic conference on 16 May to start the dialogue with all stakeholders in the sector and collect input.
Sustainable Healthcare Challenge 2019: The winners!
Op 23 mei vond de Challenge & Congress van de Sustainable Healthcare Challenge 2019 plaats. De dag stond in het teken van zorginnovatie en jong ondernemerschap. Het KPN-gebouw in Rotterdam gaf de keynote sprekers een mooi podium! In totaal kregen 15 startups de kans om te pitchen voor jury en publiek.
Erasmus MC and LUMC to co-participate in GenomeScan
Erasmus MC (Rotterdam, The Netherlands) announced today the acquisition of shares of the fast-growing genomics service provider GenomeScan BV based in Leiden (The Netherlands). Together with the Leiden University Medical Center (LUMC), another shareholder in GenomeScan, they are joining forces in the field of molecular diagnostics and research.
Call for public-private partnership projects for the development of Human Measurement Models
The Association of Dutch Health Foundations (SGF) and the Top Sector Life Sciences & Health (LSH) have made € 3.2 million PPP Allowance (financial resources for public-private partnerships) available for the development of Human Measurement Models. This call is being made in collaboration with ZonMw and NWO Domain Applied and Engineering Sciences (AES).
An impression of the succesful mission to China with Minister Hugo de Jonge
From 6 – 10 May 2019 the Embassy of the Netherlands in Beijing, the Ministry of Health, Welfare and Sport, and Task Force Health Care (TFHC) organised an ageing and elderly care mission to China, led by Minister of Health, Welfare and Sport, Hugo de Jonge.